DOCSLIB.ORG

Epigenetic Biomarker Screening by FLIM-FRET for Combination Therapy in ER+ Breast Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Epigenetic Biomarker Screening by FLIM-FRET for Combination Therapy in ER+ Breast Cancer Liu et al. Clinical Epigenetics (2019) 11:16 https://doi.org/10.1186/s13148-019-0620-6 SHORT REPORT Open Access Epigenetic biomarker screening by FLIM- FRET for combination therapy in ER+ breast cancer Wenjie Liu1,2,3†, Yi Cui1,2,4†, Wen Ren1,2 and Joseph Irudayaraj1,2,3* Abstract Hormone-dependent gene expression involves dynamic and orchestrated regulation of epigenome leading to a cancerous state. Estrogen receptor (ER)-positive breast cancer rely on chromatin remodeling and association with epigenetic factors in inducing ER-dependent oncogenesis and thus cell over-proliferation. The mechanistic differences between epigenetic regulation and hormone signaling provide an avenue for combination therapy of ER-positive breast cancer. We hypothesized that epigenetic biomarkers within single nucleosome proximity of ER- dependent genes could serve as potential therapeutic targets. We described here a Fluorescence lifetime imaging- based Förster resonance energy transfer (FLIM-FRET) methodology for biomarker screening that could facilitate combination therapy based on our study. We screened 11 epigenetic-related markers which include oxidative forms of DNA methylation, histone modifications, and methyl-binding domain proteins. Among them, we identified H4K12acetylation (H4K12ac) and H3K27 acetylation (H3K27ac) as potential epigenetic therapeutic targets. When histone acetyltransferase inhibitor targeting H4K12ac and H3K27ac was combined with tamoxifen, an enhanced therapeutic outcome was observed against ER-positive breast cancer both in vitro and in vivo. Together, we demonstrate a single molecule approach as an effective screening tool for devising targeted epigenetic therapy. Keywords: Fluorescence lifetime, Förster resonance energy transfer, Epigenetic markers, Combination therapy, Breast cancer, Histone acetylation, Anacardic acid Introduction therapy provides an alternative to further improve the Breast cancer poses a tremendous burden on health care outcomes of conventional treatments such as surgery due to its high prevalence and mortality [1, 2]. Even and chemotherapy [8]. To screen for molecular targets though substantial progress has been made to detect the in cancer therapy, traditional methods rely on estab- disease early and prolong patient survival, currently lished libraries comprising of tens of thousands of com- available treatments are far from satisfactory [3, 4]. Of pounds to assess their effects on a model cell line, which the breast cancer population, around 80% of patients are too empirical, low in efficiency, and do not account bear ER-positive tumors, and this makes hormone ther- for molecular interaction [9, 10]. Direct interactions be- apy that block the estrogen pathways a standard option tween ER and various epigenetic modifications could of treatment [5]. However, long-term hormonal therapy provide insights into its role in breast cancer develop- would result in side effects and even tumor recurrence ment as a potential therapeutic target. Such interactions which are resistant to subsequent treatments. Such could be readily and precisely evaluated by fluorescence inadequacies require more in-depth evaluation and lifetime imaging-based Förster resonance energy transfer optimization of therapies [6, 7]. Targeted molecular (FLIM-FRET) at single molecule resolution. FLIM-FRET allows for the observation of interaction * Correspondence: [email protected] and other proximity-based evaluation directly unlike †Wenjie Liu and Yi Cui contributed equally to this work. 1Department of Agricultural and Biological Engineering, Purdue University, intensity-based FRET which is susceptible to reversible West Lafayette, IN 47907, USA photobleaching or photoconversion of donor molecules 2Bindley Bioscience Center, Purdue University, West Lafayette 47907, IN, USA Full list of author information is available at the end of the article © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Liu et al. Clinical Epigenetics (2019) 11:16 Page 2 of 9 [11]. In drug discovery, FRET screening has been used to ER-dependent breast cancer. Moreover, the combin- identify molecules or drugs that dissociate DNA-protein ation of tamoxifen and anacardic acid could potentially or protein-protein interactions in search of possible in- yield a promising therapeutic strategy for ER-positive hibitors [12, 13]. Other applications of FRET include breast cancers. evaluation of apoptosis or protein aggregation for drug screening with known anticancer molecules [14, 15]. Results and discussion These applications focus on FRET screening of known FLIM-FRET screening identifies epigenetic biomarker compounds and have not been utilized to discover novel candidates for therapy therapeutic targets. We first assessed the local epigenetic changes associated Herein, we evaluate the interaction of epigenetic targets with ERα in MCF7 cells and ER-positive tumor tissue with ERα by FLIM-FRET to reveal secondary therapeutic samples from patients. The co-localization of ERα and targets. Based on our screening results, we find that epigenetic biomarkers evaluated by FRET suggests a pos- H3K27 acetylation (H3K27ac) and H4K12 acetylation sible interaction and plays a role in ER binding to ERE (H4K12ac) usually co-localize with ERα at the nanoscale genes to induce cancer cell proliferation (Fig. 1a). Utiliz- resolution and could serve as potential therapeutic targets. ing FLIM-FRET, we evaluated the molecular interactions Therefore, we assessed the effects of histone acetyltrans- of 11 different epigenetic relevant targets for possible as- ferase inhibitor (HATi) on these potential epigenetic tar- sociation with ERα in MCF7 cells. We set the FRET effi- gets. Our results show that a combination of tamoxifen ciency threshold to above 5% for target identification, and anacardic acid (AA) resulted in significant tumor sup- which indicates that the targets (ERα and epigenetic pression on MCF7 cell growth both in vitro and in mice marks) are co-localized within 10 nm from each other. A xenograft than treatment with either drug alone. Anacar- typical FRET-induced fluorescence lifetime change in dic acid not only reduces the amount of these epigenetic the ERα–ALEXA488 complex is shown in Fig. 1b. FRET modifications in vitro but also inhibits H4K12ac-estrogen analysis of the 11 epigenetic markers with ERα based on receptor element (ERE) interactions, revealing a possible immunostaining was performed to determine possible mechanism of action of AA in breast cancer treatment. As molecular interactions as epigenetic drug targets (Fig. 2a, proof of principle, we demonstrated that a FLIM-FRET b, Additional file 1: Figure S1A). Results from quantita- platform could serve as a robust and reliable method for tive screening suggest that 5-formylcytosine (5-fC), discovering novel epigenetic therapeutic targets in methyl-CpG-binding domain protein 2 (MBD2), Fig. 1 FLIM-FRET screening identifies potential epigenetic treatment targets. a Schematic illustration of possible ERα-epigenetic biomarker association in a nucleosome scale that facilitates ER-regulated gene transcription. b Typical FLIM images show control (left) and FRET (right) results as lifetime reduces with distance between donor and acceptor fluorophores. c Schematic and prototype of biopsy tissue arrays subjected to FLIM analysis Liu et al. Clinical Epigenetics (2019) 11:16 Page 3 of 9 Fig. 2 FLIM-FRET screening results from MCF7 cell and patient tissue. a Summarized lifetime information of the FRET donor (mean ± s.d.). b Calculated average FRET efficiency based on lifetime values. FRET efficiency of 5% is set as the threshold. c FLIM-FRET screening results from MCF7 cell immunostaining indicates H4K12ac, H3K27ac, MBD2, and 5fC are in close proximity with ERα. Data from 3 independent immunostains with 15 cells analyzed in each experiment. d FLIM-FRET screening from ER+ patient tissue array shows H4K12ac, H3K27ac, and MBD2 as potential treatment targets, n = 30. Data shown as boxplot with values of minimum, 5% percentile, 25% percentile, median, 75% percentile, maximum, and mean (center square marks) H3K27ac, and H4K12ac are potential candidates for epi- studies showed that H4K12ac had increasing occupancy genetic therapy (Fig. 2c). near the transcription start sites of estrogen-induced genes To further facilitate the screening outcome, we evalu- and had a stronger correlation with the ER-positive phe- ated patient tissue arrays for H4K12ac, H3K27ac, and notypes [21]. E2 stimulated H3K27ac was abundant at the MBD2 (Fig. 1c, Additional file 1: Figure S1B). We ob- distal ERE of TFF1 gene, suggesting a potential recruiting served a consistent outcome for all of these targets to be role of H3K27ac at ERE [22–24]. These findings support within 10 nm from ERα (Fig. 2d). The tissue-screening our FLIM-FRET screening results which implicate array showed excellent potential for high throughput H4K12ac and H3K27ac as potential targets in ER+ breast screening and automation with further
Load more

Recommended publications
  • Transcription Shapes Genome-Wide Histone Acetylation Patterns
    ARTICLE https://doi.org/10.1038/s41467-020-20543-z OPEN Transcription shapes genome-wide histone acetylation patterns Benjamin J. E. Martin 1, Julie Brind’Amour 2, Anastasia Kuzmin1, Kristoffer N. Jensen2, Zhen Cheng Liu1, ✉ Matthew Lorincz 2 & LeAnn J. Howe 1 Histone acetylation is a ubiquitous hallmark of transcription, but whether the link between histone acetylation and transcription is causal or consequential has not been addressed. 1234567890():,; Using immunoblot and chromatin immunoprecipitation-sequencing in S. cerevisiae, here we show that the majority of histone acetylation is dependent on transcription. This dependency is partially explained by the requirement of RNA polymerase II (RNAPII) for the interaction of H4 histone acetyltransferases (HATs) with gene bodies. Our data also confirms the targeting of HATs by transcription activators, but interestingly, promoter-bound HATs are unable to acetylate histones in the absence of transcription. Indeed, HAT occupancy alone poorly predicts histone acetylation genome-wide, suggesting that HAT activity is regulated post- recruitment. Consistent with this, we show that histone acetylation increases at nucleosomes predicted to stall RNAPII, supporting the hypothesis that this modification is dependent on nucleosome disruption during transcription. Collectively, these data show that histone acetylation is a consequence of RNAPII promoting both the recruitment and activity of histone acetyltransferases. 1 Department of Biochemistry and Molecular Biology, Life Sciences Institute, Molecular
    [Show full text]
  • Chip Validated H4k12ac (Clone RM202) Antibody with Positive and Negative Primer Sets
    www.chromatrap.com Clywedog Rd South Wrexham Industrial Estate Wrexham LL13 9XS, United Kingdom Tel: +44 (0) 1978 666239/40 Email: [email protected] ChIP Validated H4K12ac (Clone RM202) Antibody with Positive and Negative Primer Sets Catalogue no: 900025 Chromatrap®’s ChIP Validated H4K12ac Antibody with Positive and Negative Primer Set provides a complete set of tools to assist with a successful ChIP assay. Including: H4K12ac antibody, control rabbit IgG, positive and negative primer sets. The ChIP Validated H4K12ac Antibody with Positive and Negative Primer Sets is not suitable for use with non-human species. Background: Histone 4 (H4) is one of the core histone proteins, comprising the protein component of chromatin. H4 is ubiquitous within chromosomes and can be found bound to most gene sequences throughout the genome. Lysine 12 on histone 4 (H4K12) can only be acetylated and is not associated with methylation. The histone modification H4K12ac is associated with active promoter regions and has roles in activating the transcription of genes, in particular genes with roles in memory and learning. H4K12ac can have an influence on paternal inheritance in the zygote, indicating the importance of this mark for embryo development. A rabbit IgG is included in this Antibody Primer Set as a negative control for the ChIP experiment. The H4K12ac positive primer set recognises the GREB1 gene. The negative primer set recognises the SAT2 gene. Suggested Usage: Component Suggested Dilution Figure H4K12ac 2:1 (antibody: chromatin) 1 Rabbit IgG 2:1 (antibody: chromatin) 1 Positive Primer Set Dilute from 4M (provided) to 1M working concentration Negative Primer Set Dilute from 4M (provided) to 1M working concentration Please note: Optimal dilutions should be determined by the user.
    [Show full text]
  • H4k12ac Is Regulated by Estrogen Receptor-Alpha and Is Associated with BRD4 Function and Inducible Transcription
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No. 9 H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription Sankari Nagarajan1, Eva Benito2, Andre Fischer2,3 and Steven A. Johnsen1 1 Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany 2 Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany 3 Research Group for Epigenetics in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Göttingen, Göttingen, Germany Correspondence to: Steven A. Johnsen, email: [email protected] Keywords: Histone acetylation, bromodomain, estrogen, epigenetics, chromatin Received: December 04, 2014 Accepted: January 28, 2015 Published: January 31, 2015 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Hormone-dependent gene expression requires dynamic and coordinated epigenetic changes. Estrogen receptor-positive (ER+) breast cancer is particularly dependent upon extensive chromatin remodeling and changes in histone modifications for the induction of hormone-responsive gene expression. Our previous studies established an important role of bromodomain-containing protein-4 (BRD4) in promoting estrogen-regulated transcription and proliferation of ER+ breast cancer cells. Here, we investigated the association between genome-wide occupancy of histone H4 acetylation at lysine 12 (H4K12ac) and BRD4 in the context of estrogen- induced transcription. Similar to BRD4, we observed that H4K12ac occupancy increases near the transcription start sites (TSS) of estrogen-induced genes as well as at distal ERα binding sites in an estrogen-dependent manner.
    [Show full text]
  • New Insights Into the Role of Histone Changes in Aging
    International Journal of Molecular Sciences Review New Insights into the Role of Histone Changes in Aging Sun-Ju Yi and Kyunghwan Kim * Department of Biology, School of Biological Sciences, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Chungbuk, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-(43)-2612292 Received: 14 October 2020; Accepted: 2 November 2020; Published: 3 November 2020 Abstract: Aging is the progressive decline or loss of function at the cellular, tissue, and organismal levels that ultimately leads to death. A number of external and internal factors, including diet, exercise, metabolic dysfunction, genome instability, and epigenetic imbalance, affect the lifespan of an organism. These aging factors regulate transcriptome changes related to the aging process through chromatin remodeling. Many epigenetic regulators, such as histone modification, histone variants, and ATP-dependent chromatin remodeling factors, play roles in chromatin reorganization. The key to understanding the role of gene regulatory networks in aging lies in characterizing the epigenetic regulators responsible for reorganizing and potentiating particular chromatin structures. This review covers epigenetic studies on aging, discusses the impact of epigenetic modifications on gene expression, and provides future directions in this area. Keywords: aging; histone level; histone modification; histone variant; chromatin remodeling; epigenetics 1. Introduction An individual organism undergoes a series of developmental stages, including birth, growth, maturity, aging, and death. Aging is the gradual and continuous decline or loss of function at the cellular, tissue, and organismal levels with the passage of time. Aging is considered to begin in early adulthood, but is regarded as an integral part of life since other stages also affect the aging process [1].
    [Show full text]
  • Restoring Tip60 HAT/HDAC2 Balance in the Neurodegenerative Brain Relieves Epigenetic Transcriptional Repression and Reinstates C
    This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. A link to any extended data will be provided when the final version is posted online. Research Articles: Cellular/Molecular Restoring Tip60 HAT/HDAC2 balance in the neurodegenerative brain relieves epigenetic transcriptional repression and reinstates cognition Priyalakshmi Panikker, Song-Jun Xu, Haolin Zhang, Jessica Sarthi, Mariah Beaver, Avni Sheth, Sunya Akhter and Felice Elefant Department of Biology, Drexel University, Philadelphia, PA 19104, USA DOI: 10.1523/JNEUROSCI.2840-17.2018 Received: 28 September 2017 Revised: 26 March 2018 Accepted: 6 April 2018 Published: 13 April 2018 AUTHOR CONTRIBUTION: P.P., and F.E. designed the research; P.P., S.X., H.Z., J.S., M.B., A.S., and S.A conducted the experiments; P.P., S.X., H.Z., J.S., and F.E. analyzed the data; P.P. and F.E. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. The authors thank the Cell Imaging Center (CIC) at Drexel University for their imaging facilities and to Dr. Denise Garcia for generously contributing antibodies for human hippocampal immunohistochemistry. This work was supported by NIH grant R01HD057939 to F.E. Corresponding Author: Felice Elefant, Ph.D., 3245 Chestnut Street, PISB 312, Department of Biology, Drexel University, Philadelphia, PA 19104, USA.; Email: [email protected], FAX: 215-895-1273 Cite as: J. Neurosci ; 10.1523/JNEUROSCI.2840-17.2018 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published.
    [Show full text]
  • Comprehensive Analysis of Histone Post-Translational Modifications In
    Luense et al. Epigenetics & Chromatin (2016) 9:24 DOI 10.1186/s13072-016-0072-6 Epigenetics & Chromatin RESEARCH Open Access Comprehensive analysis of histone post‑translational modifications in mouse and human male germ cells Lacey J. Luense1,4†, Xiaoshi Wang2,4†, Samantha B. Schon3,4†, Angela H. Weller1,4, Enrique Lin Shiao2,4,5, Jessica M. Bryant1,4,5,6, Marisa S. Bartolomei1,4, Christos Coutifaris3, Benjamin A. Garcia2,4* and Shelley L. Berger1,4* Abstract Background: During the process of spermatogenesis, male germ cells undergo dramatic chromatin reorganization, whereby most histones are replaced by protamines, as part of the pathway to compact the genome into the small nuclear volume of the sperm head. Remarkably, approximately 90 % (human) to 95 % (mouse) of histones are evicted during the process. An intriguing hypothesis is that post-translational modifications (PTMs) decorating histones play a critical role in epigenetic regulation of spermatogenesis and embryonic development following fertilization. Although a number of specific histone PTMs have been individually studied during spermatogenesis and in mature mouse and human sperm, to date, there is a paucity of comprehensive identification of histone PTMs and their dynamics during this process. Results: Here we report systematic investigation of sperm histone PTMs and their dynamics during spermatogen- esis. We utilized “bottom-up” nanoliquid chromatography–tandem mass spectrometry (nano-LC–MS/MS) to identify histone PTMs and to determine their relative abundance in distinct stages of mouse spermatogenesis (meiotic, round spermatids, elongating/condensing spermatids, and mature sperm) and in human sperm. We detected peptides and histone PTMs from all four canonical histones (H2A, H2B, H3, and H4), the linker histone H1, and multiple histone isoforms of H1, H2A, H2B, and H3 in cells from all stages of mouse spermatogenesis and in mouse sperm.
    [Show full text]
  • Methylation Analysis of Histone H4k12ac-Associated Promoters In
    Vieweg et al. Clinical Epigenetics (2015) 7:31 DOI 10.1186/s13148-015-0058-4 RESEARCH Open Access Methylation analysis of histone H4K12ac-associated promoters in sperm of healthy donors and subfertile patients Markus Vieweg1†, Katerina Dvorakova-Hortova2,3†, Barbora Dudkova3, Przemyslaw Waliszewski4, Marie Otte5, Berthold Oels5, Amir Hajimohammad5, Heiko Turley6,MartinSchorsch6, Hans-Christian Schuppe4, Wolfgang Weidner4, Klaus Steger1 and Agnieszka Paradowska-Dogan1*† Abstract Background: Histone to protamine exchange and the hyperacetylation of the remaining histones are hallmarks of spermiogenesis. Acetylation of histone H4 at lysine 12 (H4K12ac) was observed prior to full decondensation of sperm chromatin after fertilization suggesting an important role for the regulation of gene expression in early embryogenesis. Similarly, DNA methylation may contribute to gene silencing of several developmentally important genes. Following the identification of H4K12ac-binding promoters in sperm of fertile and subfertile patients, we aimed to investigate whether the depletion of histone-binding is associated with aberrant DNA methylation in sperm of subfertile men. Furthermore, we monitored the transmission of H4K12ac, 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) from the paternal chromatin to the embryo applying mouse in vitro fertilization and immunofluorescence. Results: Chromatin immunoprecipitation (ChIP) with anti-H4K12ac antibody was performed with chromatin isolated from spermatozoa of subfertile patients with impaired sperm
    [Show full text]
  • Fluctuations of Histone Chemical Modifications in Breast, Prostate
    biomolecules Review Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium 1, 1, 1 2 Marek Samec y, Alena Liskova y, Lenka Koklesova , Veronika Mestanova , Maria Franekova 3, Monika Kassayova 4, Bianka Bojkova 4 , Sona Uramova 5, Pavol Zubor 6, Katarina Janikova 7, Jan Danko 1, Samson Mathews Samuel 8 , Dietrich Büsselberg 8,* and Peter Kubatka 3,* 1 Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 03601 Martin, Slovakia; [email protected] (M.S.); [email protected] (A.L.); [email protected] (L.K.); [email protected] (J.D.) 2 Department of Histology and Embryology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 03601 Martin, Slovakia; [email protected] 3 Department of Medical Biology and Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, 03601 Martin, Slovakia; [email protected] 4 Department of Animal Physiology, Institute of Biology and Ecology, Faculty of Science, Pavol Jozef Safarik University, 04001 Kosice, Slovakia; [email protected] (M.K.); [email protected] (B.B.) 5 Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, 03601 Martin, Slovakia; [email protected] 6 OBGY Health & Care, Ltd., 01026 Zilina, Slovakia; [email protected] 7 Department of Pathological Anatomy, Jessenius Faculty of Medicine, Comenius University in Bratislava, 03601 Martin, Slovakia; [email protected] 8 Department of Physiology and Biophysics, Weill Cornell Medicine in Qatar, Education City, Qatar Foundation, Doha 24144, Qatar; [email protected] * Correspondence: [email protected] (P.K.); [email protected] (D.B.); Tel.: 421-43/2633408 (P.K.) Co-first/equal authorship.
    [Show full text]
  • H4k12ac Monoclonal Antibody
    H4K12ac monoclonal antibody Cat. No. C15200218 Specificity: Human: positive Type: Monoclonal ChIP-grade Other species: not tested Source: Mouse Purity: Protein A purified monoclonal antibody in PBS containing 0.05% azide. Lot #: 001-11 Storage: Store at -20°C; for long storage, store at -80°C. Size: 50 µg/ 50 µl Avoid multiple freeze-thaw cycles. Concentration: 1 µg/µl Precautions: This product is for research use only. Not for use in diagnostic or therapeutic procedures. Description: Monoclonal antibody raised in mouse against histone H4, aceylated at lysine 12 (H4K12ac), using a KLH- conjugated synthetic peptide. Applications Suggested dilution Results ChIP* 1-2 µg/ChIP Fig 1 Western blotting 1:500 Fig 2 * Please note that the optimal antibody amount per IP should be determined by the end-user. We recommend testing 1-5 µg per IP. Target description Histones are the main constituents of the protein part of chromosomes of eukaryotic cells. They are rich in the amino acids arginine and lysine and have been greatly conserved during evolution. Histones pack the DNA into tight masses of chromatin. Two core histones of each class H2A, H2B, H3 and H4 assemble and are wrapped by 146 base pairs of DNA to form one octameric nucleosome. Histone tails undergo numerous post-translational modifications, which either directly or indirectly alter chromatin structure to facilitate transcriptional activation or repression or other nuclear processes. In addition to the genetic code, combinations of the different histone modifications reveal the so-called “histone code”. Histone methylation and demethylation is dynamically regulated by respectively histone methyl transferases and histone demethylases.
    [Show full text]
  • Li Et Al., Sci
    DNA polymerase α interacts with H3-H4 and facilitates the transfer of parental histones to lagging strands Zhiming Li, Xu Hua, Albert Serra-Cardona, Xiaowei Xu, Songlin Gan, Hui Zhou, Wen-Si Yang, Chun-Long Chen, Rui-Ming Xu, Zhiguo Zhang To cite this version: Zhiming Li, Xu Hua, Albert Serra-Cardona, Xiaowei Xu, Songlin Gan, et al.. DNA polymerase α interacts with H3-H4 and facilitates the transfer of parental histones to lagging strands. Science Advances , American Association for the Advancement of Science (AAAS), 2020, 6 (35), pp.eabb5820. 10.1126/sciadv.abb5820. hal-03015005 HAL Id: hal-03015005 https://hal.archives-ouvertes.fr/hal-03015005 Submitted on 24 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. SCIENCE ADVANCES | RESEARCH ARTICLE MOLECULAR BIOLOGY Copyright © 2020 The Authors, some a rights reserved; DNA polymerase interacts with H3-H4 and facilitates exclusive licensee American Association the transfer of parental histones to lagging strands for the Advancement Zhiming Li1,2,3,4*, Xu Hua1,2,3,4*, Albert Serra-Cardona1,2,3,4*, Xiaowei Xu1,2,3,4*, Songlin Gan5,6, of Science. No claim to 1,2,3,4 5,6 7,8 5,6 1,2,3,4† original U.S.
    [Show full text]
  • Hdacs, Histone Deacetylation and Gene Transcription: from Molecular Biology to Cancer Therapeutics
    Paola Gallinari et al. npg Cell Research (2007) 17:195-211. npg195 © 2007 IBCB, SIBS, CAS All rights reserved 1001-0602/07 $ 30.00 REVIEW www.nature.com/cr HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics Paola Gallinari1, Stefania Di Marco1, Phillip Jones1, Michele Pallaoro1, Christian Steinkühler1 1Istituto di Ricerche di Biologia Molecolare “P. Angeletti”-IRBM-Merck Research Laboratories Rome, Via Pontina Km 30,600, 00040 Pomezia, Italy Histone deacetylases (HDACs) and histone acetyl transferases (HATs) are two counteracting enzyme families whose enzymatic activity controls the acetylation state of protein lysine residues, notably those contained in the N-terminal extensions of the core histones. Acetylation of histones affects gene expression through its influence on chromatin confor- mation. In addition, several non-histone proteins are regulated in their stability or biological function by the acetylation state of specific lysine residues. HDACs intervene in a multitude of biological processes and are part of a multiprotein family in which each member has its specialized functions. In addition, HDAC activity is tightly controlled through targeted recruitment, protein-protein interactions and post-translational modifications. Control of cell cycle progression, cell survival and differentiation are among the most important roles of these enzymes. Since these processes are affected by malignant transformation, HDAC inhibitors were developed as antineoplastic drugs and are showing encouraging efficacy in cancer patients. Keywords: histone deacetylase, histone, post-translational modification, transcription, histone deacetylase inhibitors, protein acetylation Cell Research (2007) 17:195-211. doi: 10.1038/sj.cr.7310149; published online 27 February 2007 Introduction tone deacetylase (HDAC) family of chromatin-modifying enzymes.
    [Show full text]
  • Nucleosome, Recombinant Human, H4 K12ac Dnuc Catalog No
    Nucleosome, Recombinant Human, H4 K12Ac dNuc Catalog No. 16-0312 Lot No. 17031003 Pack Size 50 µg Product Description: Mononucleosomes assembled from recombinant human histones expressed in E. coli (two each of histones H2A, H2B, H3 and H4; accession numbers: H2A-P04908; H2B-O60814; H3.1-P68431; H4- P62805) wrapped by 147 base pairs of 601 positioning sequence DNA. Histone H4 (created by a proprietary fully synthetic method) contains acetyl-lysine at position 12. The nucleosome is the basic subunit of chromatin. The 601 sequence, identified by Lowary and Widom, is a 147-base pair sequece that has high affinity for histone octamers and is useful for nucleosome assembly and contains a 5’ biotin-TEG group. Formulation: Nucleosome, Recombinant Human, H4 K12Ac (27.3 µg protein weight, 50.0 µg DNA+protein) in 21.2 µl 10mM Western Blot Data: Western blot analysis of Nucleosome, Tris HCl, pH 7.5, 25mM NaCl, 1mM EDTA, 2mM DTT, 20% Recombinant Human, H4 K12Ac. Top Panel: Unmodified glycerol. Molarity = 10.78 µmolar. MW = 200,905 Da. recombinant H4 (Lane 1) and H4K12Ac containing nucleosomes (Lane 2) were probed with an anti-H4K12Ac antibody and detected via ECL. Only the H4K12Ac dNuc sample produced a detectable Storage and Stability: signal. Bottom Panel: Detail from Coomassie stained gel showing Stable for six months at -80°C from date of receipt. For recombinant H4 protein (Lane 1) and all four histones from H4 K12Ac nucleosome (Lane 2). best results, aliquot and avoid multiple freeze/thaws. Application Notes: Nucleosome, Recombinant Human, H4 K12Ac are highly purified and are suitable for use as substrates in enzyme screening assays or for effector protein (especially bromodomain) binding experiments.
    [Show full text]